Seasoned clinical leader to oversee Phase 3 development of pemvidutide in MASH. Dr. Arbet-Engels has led late-stage development, regulatory approvals and commercial launches for m ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback